Dr. Paymohn Mahdavi, MD

Dr. Mahdavi practices at Azul Vision in Redlands, California.

Dr. Mahdavi's NPI, 1295095669, was assigned on May 20, 2012. Dr. Mahdavi graduated from Loma Linda University School Of Medicine in 2012. Dr. Mahdavi holds California license A162708.

Dr. Mahdavi's primary practice is Azul Vision, at 1845 W Redlands Blvd, Redlands, CA 92373 in San Bernardino County. The practice phone is (626) 793-4168.

Dr. Mahdavi's primary practice is Azul Vision in Redlands, California. Dmand AI also links Dr. Mahdavi to 5 medical groups and 4 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mahdavi practices, 4 sites in all. Vendor and product names are available with a free account.

Retina specialist is Dr. Mahdavi's primary specialty in the NPI Registry, under taxonomy code 207WX0107X. Dr. Mahdavi is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Mahdavi's licenses on file in 5 states: California, Ohio, Maryland, Virginia and New York.

Dmand AI lists age-related macular degeneration, cold sores or genital herpes, conjunctivitis, dry eye, glaucoma, hypertensive retinopathy, inflammation of iris and laser destruction of retinal or choroid lesions among the conditions Dr. Mahdavi treats.

CMS data shows 18 Medicare services from Dr. Mahdavi across 1 procedure code in 2024, for 16 Medicare patients. Medicare paid $632 for them. Every service was in an office.

CMS counts 16 Medicare patients who saw Dr. Mahdavi in 2024. 75% of them have high cholesterol, and 69% have diabetes. Their average risk score is 2.01, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mahdavi's median patient age at 70, with 54% women.

In 2024, Dr. Mahdavi wrote 2,911 Medicare Part D claims for 816 patients. 61% of them were for generic drugs. CMS names the drug for 2,781 of them, across 21 drugs with 11 or more claims each, at $160,497 in total drug cost. In 2023, CMS named 540 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Mahdavi for performance year 2024, reported as part of a group. Dr. Mahdavi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 55 general payments to Dr. Mahdavi from 20 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 87% of the total. ANI Pharmaceuticals, Inc. paid the most, $473.

Dr. Mahdavi graduated from Loma Linda University School Of Medicine in 2012.

Dr. Mahdavi is in network with 20 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.